Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
| ▸ | GPR132 | Q9UNW8 | 4/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 4/20 | 0.46 |
| ▸ | CMKLR2 | P46091 | 1/20 | 0.45 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30958913 | 0.94 | BACE1 (0.54) | NAALAD2BACE1BACE2 | |
| SCHEMBL29375944 | 0.91 | NAALAD2 (0.51) | NAALAD2GPR132FOLH1TBXAS1MMP9 | |
| SCHEMBL4198783 | 0.89 | GPR132 (0.52) | GPR132FOLH1CMKLR2CMKLR1TBXAS1 | |
| SCHEMBL31754274 | 0.87 | FOLH1 (0.48) | GPR132FOLH1CMKLR2CMKLR1HDAC3 | |
| SCHEMBL3732243 | 0.86 | NAALAD2 (0.68) | NAALAD2BACE1BACE2MME | |
| SCHEMBL3748615 | 0.86 | NAALAD2 (0.68) | NAALAD2BACE1BACE2MME | |
| SCHEMBL29602993 | 0.86 | NAALAD2 (0.68) | NAALAD2BACE1BACE2MME | |
| SCHEMBL27914476 | 0.86 | NAALAD2 (0.68) | NAALAD2BACE1BACE2MME | |
| SCHEMBL2980529 | 0.86 | NAALAD2 (0.68) | NAALAD2BACE1BACE2MME | |
| SCHEMBL31000651 | 0.86 | MME (0.50) | GPR132FOLH1CMKLR2CMKLR1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131339-A1 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | BADEN-WUERTTEMBERG STIFTUNG GGMBH (DE) | 2023-04-27 | — | — | US | claimed |
| EP-4110790-A2 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | Universität Ulm (DE) | 2023-01-04 | — | — | EP | claimed |
| EP-4574166-A2 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | JANSSEN Pharmaceutica NV (BE) | 2025-06-25 | — | — | EP | disclosed |
| EP-3988123-B1 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | JANSSEN PHARMACEUTICA NV (BE) | 2025-02-26 | — | — | EP | disclosed |
| WO-2023105497-A1 | SYNTHESIS OF GLP-1 ANALOGUES | ANTHEM BIOSCIENCES PVT. LTD. (IN) | 2023-06-15 | — | — | WO | disclosed |
| US-20230131339-A1 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | BADEN-WUERTTEMBERG STIFTUNG GGMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| EP-4110790-A2 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | Universität Ulm (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-3988123-A1 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | Janssen Pharmaceutica NV (BE) | 2022-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131339-A1 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | CXCR4, SDF4, ACKR3 | NAALAD2 741/4885GPR132 573/4885FOLH1 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.